...We Welcome You to the Zenith Epigenetics Hub In The AGORACOM COMMUNITY!
Zenith's Lead BET Inhibitor ZEN-3694 is Currently Being Evaluated in a Phase 2 Prostate Cancer Clinical Trial
fast facts
- name Zenith Epigenetics
- symbol ZZXY
- exchange OTCBB
- financials View Filings
- shares outstanding 129,170,628
- industry Technology & Medical
- transfer agent Computershare Trust Company of Canada
- website http://www.zenithepigenet...
recent updates
-
WebLink -
BIO-Europe Nov 6, 2018 -
-
-
WebLink -
Zenith_AGM_2018_09_12... (rough) -
most recent messages
